Connection

ANDREA CRUZ to Antitubercular Agents

This is a "connection" page, showing publications ANDREA CRUZ has written about Antitubercular Agents.
Connection Strength

4.566
  1. Completion, Safety and Tolerability of Once-weekly Isoniazid and Rifapentine for Tuberculosis Infection by Children and Adolescents. Pediatr Infect Dis J. 2025 Feb 14; 44(8):755-758.
    View in: PubMed
    Score: 0.769
  2. Monitoring Treatment of Childhood Tuberculosis and the Role of Therapeutic Drug Monitoring. Indian J Pediatr. 2019 08; 86(8):732-739.
    View in: PubMed
    Score: 0.508
  3. Treatment of Multidrug-Resistant Tuberculosis Infection in Children. Pediatr Infect Dis J. 2018 10; 37(10):1061-1064.
    View in: PubMed
    Score: 0.494
  4. Treatment of Multidrug-resistant Tuberculosis Infection in Children. Pediatr Infect Dis J. 2018 08; 37(8):831-834.
    View in: PubMed
    Score: 0.489
  5. Completion Rate and Safety of Tuberculosis Infection Treatment With Shorter Regimens. Pediatrics. 2018 02; 141(2).
    View in: PubMed
    Score: 0.472
  6. Twice-weekly therapy for children with tuberculosis infection or exposure. Int J Tuberc Lung Dis. 2013 Feb; 17(2):169-74.
    View in: PubMed
    Score: 0.334
  7. Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy. Pediatr Infect Dis J. 2012 Feb; 31(2):193-5.
    View in: PubMed
    Score: 0.311
  8. Treatment of tuberculosis in children. Expert Rev Anti Infect Ther. 2008 Dec; 6(6):939-57.
    View in: PubMed
    Score: 0.250
  9. Using Changes in Weight-for-Age z Score to Predict Effectiveness of Childhood Tuberculosis Therapy. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):150-158.
    View in: PubMed
    Score: 0.138
  10. New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations. Am J Respir Crit Care Med. 2017 05 15; 195(10):1300-1310.
    View in: PubMed
    Score: 0.112
  11. Tuberculosis Cervical Adenitis: Management Dilemmas. Pediatr Infect Dis J. 2016 10; 35(10):1154-6.
    View in: PubMed
    Score: 0.108
  12. Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study. Clin Infect Dis. 2016 10 15; 63(8):1063-71.
    View in: PubMed
    Score: 0.106
  13. Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection. Pediatr Infect Dis J. 2016 Jul; 35(7):811-3.
    View in: PubMed
    Score: 0.106
  14. Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries. Curr Opin Pediatr. 2014 Feb; 26(1):106-13.
    View in: PubMed
    Score: 0.089
  15. Pediatric tuberculosis. Pediatr Rev. 2010 Jan; 31(1):13-25; quiz 25-6.
    View in: PubMed
    Score: 0.067
  16. Childhood pleural tuberculosis: a review of 45 cases. Pediatr Infect Dis J. 2009 Nov; 28(11):981-4.
    View in: PubMed
    Score: 0.067
  17. Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2023 07 15; 208(2):130-131.
    View in: PubMed
    Score: 0.043
  18. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020 01; 4(1):68-79.
    View in: PubMed
    Score: 0.033
  19. School-based Study to Identify and Treat Adolescent Students at Risk for Tuberculosis Infection. Pediatr Infect Dis J. 2016 07; 35(7):733-8.
    View in: PubMed
    Score: 0.026
  20. Neurologic deterioration in a child undergoing treatment for tuberculosis meningitis. Pediatr Emerg Care. 2014 Aug; 30(8):566-7.
    View in: PubMed
    Score: 0.023
  21. Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J Infect Dis. 2012 May 15; 205 Suppl 2:S209-15.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.